SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,052.44 |
| Enterprise Value ($M) | 991.27 |
| Book Value ($M) | 264.45 |
| Book Value / Share | 2.48 |
| Price / Book | 3.98 |
| NCAV ($M) | 210.27 |
| NCAV / Share | 1.97 |
| Price / NCAV | 5.01 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.37 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.23 |
| Current Ratio | 8.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 352.04 |
| Assets | 406.22 |
| Liabilities | 141.77 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 36.53 |
| Operating Income | -114.17 |
| Net Income | -101.74 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -117.98 |
| Cash from Investing | 41.43 |
| Cash from Financing | 82.41 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Southpoint Capital Advisors LP | 4.90 | 0.00 | |
| 13G/A | Gilead Sciences Inc | 4.80 | 0.00 | |
| 13G/A | Fmr Llc | 9.60 | -27.76 | |
| 13D/A | BCTG Holdings, LLC | 15.00 | 7.60 | |
| 13G/A | EcoR1 Capital, LLC | 13.10 | 70.30 | |
| 13G | Nextech Crossover I GP S.a r.l. | 5.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 120,899 | 694,957 | 17.40 | |
| 129,098 | 549,954 | 23.47 | |
| 255,049 | 686,623 | 37.15 | |
| 231,798 | 701,406 | 33.05 | |
| 444,624 | 1,331,842 | 33.38 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TENK – TenX Keane Acquisition | TKNO – Alpha Teknova, Inc. |
| TLPH – Talphera, Inc. | TRDA – Entrada Therapeutics, Inc. |
| TRVI – Trevi Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io